Literature DB >> 28049601

Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis View.

Grazia Canciello1, Giovanni de Simone2, Raffaele Izzo1, Alessandra Giamundo3, Filomena Pacelli3, Costantino Mancusi1, Maurizio Galderisi3, Bruno Trimarco3, Maria-Angela Losi3.   

Abstract

BACKGROUND: Measurement of left atrial (LA) volume (LAV) is recommended for quantification of LA size. Only LA anteroposterior diameter (LAd) is available in a number of large cohorts, trials, or registries. The aim of this study was to evaluate whether LAV may be reasonably estimated from LAd.
METHODS: One hundred forty consecutive patients referred to our outpatient clinics were prospectively enrolled to measure LAd from the long-axis view on two-dimensional echocardiography. LA orthogonal dimensions were also taken from apical four- and two-chamber views. LAV was measured using the Simpson, area-length, and ellipsoid (LAVe) methods. The first 70 patients were the learning series and the last 70 the testing series (TeS). In the learning series, best-fitting regression analysis of LAV-LAd was run using all LAV methods, and the highest values of F were chosen among the regression equations. In the TeS, the best-fitting regressions were used to estimate LAV from LAd.
RESULTS: In the learning series, the best-fitting regression was linear for the Spearman method (r2 = 0.62, F = 111.85, P = .0001) and area-length method (r2 = 0.62, F = 112.24, P = .0001) and powered for the LAVe method (r2 = 0.81, F = 288.41, P = .0001). In the TeS, the r2 value for LAV prediction was substantially better using the LAVe method (r2 = 0.89) than the Simpson (r2 = 0.72) or area-length (r2 = 0.70) method, as was the intraclass correlation (ρ = 0.96 vs ρ = 0.89 and ρ = 0.89, respectively). In the TeS, the sensitivity and specificity of LA dilatation by the estimated LAVe method were 87% and 90%, respectively.
CONCLUSIONS: LAV can be estimated from LAd using a nonlinear equation with an elliptical model. The proposed method may be used in retrospective analysis of existing data sets in which determination of LAV was not programmed.
Copyright © 2016 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; Left atrial diameter; Left atrial size; Left atrial volume

Mesh:

Year:  2016        PMID: 28049601     DOI: 10.1016/j.echo.2016.11.017

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  10 in total

1.  Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging.

Authors:  Maria Angela Losi; Massimo Imbriaco; Grazia Canciello; Filomena Pacelli; Carlo Di Nardo; Raffaella Lombardi; Raffaele Izzo; Costantino Mancusi; Andrea Ponsiglione; Serena Dell'Aversana; Alberto Cuocolo; Giovanni de Simone; Bruno Trimarco; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2019-09-05       Impact factor: 4.132

2.  Effect of ingesting carbohydrate only or carbohydrate plus casein protein hydrolysate during a multiday cycling race on left ventricular function, plasma volume expansion and cardiac biomarkers.

Authors:  Tanja Oosthuyse; Andrew N Bosch; Aletta M E Millen
Journal:  Eur J Appl Physiol       Date:  2019-01-04       Impact factor: 3.078

3.  Low mechano-energetic efficiency is associated with future left ventricular systolic dysfunction in hypertensives.

Authors:  Maria V Manzi; Costantino Mancusi; Maria Lembo; Giovanni Esposito; Maria A E Rao; Giovanni de Simone; Carmine Morisco; Valentina Trimarco; Raffaele Izzo; Bruno Trimarco
Journal:  ESC Heart Fail       Date:  2022-04-28

Review 4.  Echocardiography in Arterial Hypertension.

Authors:  Giovanni de Simone; Costantino Mancusi; Roberta Esposito; Nicola De Luca; Maurizio Galderisi
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-05-02

5.  Adverse cardiac mechanics and incident coronary heart disease in the Cardiovascular Health Study.

Authors:  Daniele Massera; Mo Hu; Joseph A Delaney; Traci M Bartz; Megan E Bach; Stephen J Dvorak; Christopher R DeFilippi; Bruce M Psaty; John S Gottdiener; Jorge R Kizer; Sanjiv J Shah
Journal:  Heart       Date:  2021-07-13       Impact factor: 5.994

6.  Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study.

Authors:  Giovanni de Simone; Wenyu Wang; Lyle G Best; Fawn Yeh; Raffaele Izzo; Costantino Mancusi; Mary J Roman; Elisa T Lee; Barbara V Howard; Richard B Devereux
Journal:  Cardiovasc Diabetol       Date:  2017-05-12       Impact factor: 9.951

7.  CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry.

Authors:  Antonio Rapacciuolo; Costantino Mancusi; Grazia Canciello; Raffaele Izzo; Teresa Strisciuglio; Nicola de Luca; Giuseppe Ammirati; Giovanni de Simone; Bruno Trimarco; Maria-Angela Losi
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

8.  Determinants of improvement of left ventricular mechano-energetic efficiency in hypertensive patients.

Authors:  Maria Lembo; Valentina Trimarco; Maria Virginia Manzi; Costantino Mancusi; Giovanni Esposito; Salvatore Esposito; Carmine Morisco; Raffaele Izzo; Bruno Trimarco
Journal:  Front Cardiovasc Med       Date:  2022-07-28

9.  Left atrial enlargement as a maker of significant high-risk patent foramen ovale.

Authors:  Gianluca Rigatelli; Marco Zuin; Alessandro Adami; Silvio Aggio; Daniela Lanza; Katia d'Elia; Gabriele Braggion; Monia Russo; Alberto Mazza; Loris Roncon
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-19       Impact factor: 2.357

10.  Prevention of sudden cardiac death in hypertrophic cardiomyopathy: Risk assessment using left atrial diameter predicted from left atrial volume.

Authors:  Helen Mills; Kiri Espersen; Rebecca Jurlander; Kasper Iversen; Henning Bundgaard; Anna Axelsson Raja
Journal:  Clin Cardiol       Date:  2020-03-07       Impact factor: 2.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.